HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduction of enzymatic activity of tyrosine hydroxylase by a heterocyclic amine, 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole (Trp-P-1), was due to reduced affinity to a cofactor biopterin.

Abstract
A carcinogenic, food-derived heterocyclic amine, 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole (Trp-P-1) was found to reduce the enzymatic activity of tyrosine hydroxylase in clonal rat pheochromocytoma PC12h cells, by its supplement to the culture medium. The reduction was observed with 10 microM Trp-P-1, and at this concentration the amount of cell protein and the activity of a non-specific enzyme, beta-galactosidase, were not affected. The mechanism of the reduction of the enzyme activity was clarified by kinetical studies. The amine reduced the affinity of tyrosine hydroxylase to a cofactor, tetrahydrobiopterin. The alteration of the enzymatic properties by Trp-P-1 was discussed in relation to the possible effect on catecholamine metabolism in the brain.
AuthorsW Maruyama, M Minami, A Ota, T Takahashi, A Takahashi, T Nagatsu, M Naoi
JournalNeuroscience letters (Neurosci Lett) Vol. 125 Issue 1 Pg. 85-8 (Apr 15 1991) ISSN: 0304-3940 [Print] Ireland
PMID1677462 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carbolines
  • Mutagens
  • 3,4-Dihydroxyphenylacetic Acid
  • Biopterin
  • Dihydroxyphenylalanine
  • Tyrosine 3-Monooxygenase
  • 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole
  • Dopamine
Topics
  • 3,4-Dihydroxyphenylacetic Acid (metabolism)
  • Adrenal Gland Neoplasms
  • Animals
  • Biopterin (metabolism)
  • Carbolines (pharmacology)
  • Cell Line
  • Dihydroxyphenylalanine (metabolism)
  • Dopamine (metabolism)
  • Kinetics
  • Mutagens (pharmacology)
  • Pheochromocytoma
  • Protein Binding
  • Rats
  • Tyrosine 3-Monooxygenase (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: